Alexandra Voß
Plus aucun poste en cours
Profil
Alexandra Voß has founded two companies named NeuroProof GmbH in 2007.
Anciens postes connus de Alexandra Voß
| Sociétés | Poste | Fin |
|---|---|---|
NeuroProof GmbH
 NeuroProof GmbH Information Technology ServicesTechnology Services NeuroProof GmbH provides screening services for pre-clinical development of neuro-pharmaceuticals. It offers phenotypic profiling, cell viability and cytotoxicity, target validation, combination and adjunctive, and data analysis. The company was founded by Olaf Schröder, Alexandra Voß, and Dieter G. Weiss in 2007 and is headquartered in Rostock, Germany. | Fondateur | - |
NeuroProof GmbH /Old/
 NeuroProof GmbH /Old/ BiotechnologyHealth Technology NeuroProof GmbH provides pre-clinical data on the electro-physiological properties of drug candidates for diseases of the central nervous system. Its services include phenotypic profiling, disease models, cell viability & cytotoxicity, target validation, neurogenesis/development, combination & adjunctive therapy, prediction of side effects, stem cells and data analysis. The company was founded by Olaf Schroder, Alexandra Voß and Dieter G. Weiss in 2007 and is headquartered in Rostock, Germany. | Fondateur | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
NeuroProof GmbH /Old/
NeuroProof GmbH /Old/ BiotechnologyHealth Technology NeuroProof GmbH provides pre-clinical data on the electro-physiological properties of drug candidates for diseases of the central nervous system. Its services include phenotypic profiling, disease models, cell viability & cytotoxicity, target validation, neurogenesis/development, combination & adjunctive therapy, prediction of side effects, stem cells and data analysis. The company was founded by Olaf Schroder, Alexandra Voß and Dieter G. Weiss in 2007 and is headquartered in Rostock, Germany. | Health Technology |
NeuroProof GmbH
NeuroProof GmbH Information Technology ServicesTechnology Services NeuroProof GmbH provides screening services for pre-clinical development of neuro-pharmaceuticals. It offers phenotypic profiling, cell viability and cytotoxicity, target validation, combination and adjunctive, and data analysis. The company was founded by Olaf Schröder, Alexandra Voß, and Dieter G. Weiss in 2007 and is headquartered in Rostock, Germany. | Technology Services |
